Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Saudi Journal of MedicineOpen Access

Local Manufacturing of Insulin in Saudi Arabia: Advancing Healthcare and Economic Growth

View Full Paper
Ask AI
Bookmark
Share

Authors

YAYasser AlbarakahAAAbdulghani AlsaeedAAAbdullah Alshahrani

Discussion

Loading...

Member takes

Overview

Case study reveals local insulin production could enhance affordability and health security in Saudi Arabia, highlighting economic benefits.

Key Points

  • Local insulin manufacturing aims to meet 50% of the Kingdom's demand by 2027, boosting healthcare access.
  • The initiative could reduce healthcare expenditures associated with imported insulin, benefiting the national economy.
  • Public-private partnerships and regulatory reforms are crucial for developing a strong biopharmaceutical sector.
  • Saudi Arabia seeks to become the first GCC country to produce innovative insulins, such as Degludec and IDegAsp.

Cite This Study

Albarakah et al. (2025) studied this question.

synapsesocial.com/papers/68c23b08b210217d6478275ahttps://doi.org/10.36348/sjm.2025.v10i08.008
View Full Paper
Ask AI
Bookmark
Share